You are here

Bioniz

Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1

Pharmaforum

Wed, 01/8/20 - 11:36 pm

From Iran To CEO Of A Biotech Startup, Bioniz, With No Revenue But A $400 Million Valuation

Forbes

Wed, 12/20/17 - 10:47 am

Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch

Endpoints

Mon, 08/1/16 - 09:44 am

peptide platform